ð ç« æ«éèš
Ebola
- ssRNA Filovirus, 6 species (Zaire deadliest)
- Fruit bat reservoir
- Body fluid + sexual + vertical + healthcare transmission
- Clinical: febrile â GI â hemorrhagic â shock/MOF
- Mortality 25-90% (Zaire worst)
- Treatment: supportive + mAbs (Inmazeb, Ebanga) â FDA 2020
- Vaccine: Ervebo (rVSV-ZEBOV) â single dose, ring vaccination, Zaire only
- Janssen 2-dose heterologous prime-boost preventive
- Post-Ebola syndrome + sexual transmission risk weeks-months
Marburg
- Filoviridae family; Rousettus cave-dwelling bat
- 2024 Rwanda outbreak ongoing
- No licensed vaccine yet; emergency rollout 2025
- Similar clinical + treatment to Ebola
Both
- BSL-4 lab; strict PPE
- WHO emergency response
- Ring vaccination + mAb breakthrough therapies
- 2023-2024 ongoing African outbreaks (Sudan Ebola Uganda + Marburg Equatorial Guinea + Rwanda)
- Sexual transmission survivor counseling
- Returning traveler workup (isolate + Public Health notify)